Updated combined analysis of two phase II studies of brentuximab vedotin in patients with mycosis fungoides and Sézary syndrome
Huen, Auris, Rahbar, Z., Talpur, R., Li, S., Hong, E.K., Tetzlaff, M., Duvic, M., Kim, Y.H.Volume:
101
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2018.07.305
Date:
September, 2018
File:
PDF, 45 KB
english, 2018